| 英文摘要 |
Gynecologic malignancies pose a significant threat to women’s health; however, many lack specific symptoms in their early stages, frequently leading to delayed diagnosis. This review integrates epidemiological evidence, international clinical guidelines, and current literature to systematically summarize the early warning signs and initial evaluation strategies for cervical cancer, endometrial cancer, and ovarian cancer. Particular emphasis is placed on the importance of symptom-oriented recognition, as well as the clinical roles of current screening tools, imaging modalities, and emerging molecular diagnostic approaches. The evidence indicates that increasing frontline physicians’awareness of abnormal uterine bleeding, nonspecific abdominal symptoms, and high-risk populations—combined with guideline-based risk stratification and timely referral—remains essential for improving early diagnosis and clinical outcomes in gynecologic cancers. |